BackHeron Therapeutics Overview

Heron Therapeutics Gross Profit

Gross Profit analysis for HRTX.

Quarterly Gross Profit

$24.07M
20.93% YoY

As of Mar 31, 2026

Annual Gross Profit (TTM)

$107.18M
2.43% YoY

Trailing 12 months ending Mar 31, 2026

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)